Event Data
{"title":"Demystifying Drug Dosing in Renal Dysfunction","subtitle":"","e_issn":null,"url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=e600tww&AN=1912355&site=ehost-live&scope=site","series":"","edition":"","author":"Branden Nemecek","contract_publisher":"","imprint_publisher":"ASHP","pub_year":"2019","interest_area":["Urology & Nephrology"],"lcc":"RC918.R4","lcsh":"Chronic renal failure--Complications.,Drugs--Dosage.","language":"eng","format":"EPUB,PDF","downloadable":"TRUE","fiction":"FALSE","abridged":"","book_id":"2235001","isbn":"9781585285518","eisbn":"9781585285525","ocn":"1114975719","ddc":"616.6\/1061","isPdfLink":false,"isSAML":true,"an":"1912355","number_other":"","type_pub":"","isbn_print":"9781681087160","isbn_electronic":"9781681087153","languages":"English","date_entry":"","date_update":"","doi":"","titleSource":"","date_pub_cy":"","type_document":"","authored_on":"2018-01-01","description":"Alzheimer's Disease (AD) is the product of the slow and progressive degenerative alteration that develops in the adult brain and can remain asymptomatic for a considerable time before cognitive deficits becomes evident. The main challenge for researchers is to identify markers of this degenerative process, and, in this sense, data has been generated through experiments bringing to light new mechanisms and hypothesis to explain its pathophysiology. This book is a review of recent studies in AD molecular biology. Chapters explain various facets of AD, which include animal models, morphological changes, membrane composition, amyloidogenic peptides, intracellular transport systems, and the role of oxidative stress and calcium deregulation. Readers will understand the molecular mechanisms behind AD and therefore broaden their perspective on this neurodegenerative disease and its progression.","publication_date":"2018-01-01","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=nlebk&AN=2235001&authtype=shib&custid=ns346513&group=main&profile=eds","no_of_pages":"","authored_by":"Fernando A. Oliveira, Fernando A. Oliveira","header":{"DbId":"nlebk","DbLabel":"eBook Collection (EBSCOhost)","An":"2235001","RelevancyScore":"1090","PubType":"eBook","PubTypeId":"ebook","PreciseRelevancyScore":"1090.09973144531"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=nlebk&AN=2235001&authtype=shib&custid=ns346513&group=main&profile=eds","volume":"00002","additionalInfo":{"Authored_By":"Branden Nemecek, Branden Nemecek","Categories":"MEDICAL \/ Pharmacy","Subjects":"Drugs--Dosage, Chronic renal failure--Complications","Electronic_ISBN":"9781585285532","Print_ISBN":"9781585285518","Languages":"English","Published_Date":"2019-01-01","Resource_Type":"eBook.","Title_Abbreviations":"Demystifying Drug Dosing in Renal Dysfunction"}}
Additional Info
["Branden Nemecek, Branden Nemecek","MEDICAL \/ Pharmacy","Drugs--Dosage, Chronic renal failure--Complications","9781585285532","9781585285518","English","2019-01-01","eBook.","Demystifying Drug Dosing in Renal Dysfunction"]
Description
Chronic kidney disease affects approximately 10% of adults in the United States or approximately 20 million individuals. Further, recent studies have shown that improper dosing in patients with renal dysfunction occurs over 20% of the time. ASHP's Demystifying Drug Dosing in Renal Dysfunction addresses the persistent and challenging problem of dosing medications for patients with renal insufficiency and dysfunction.
